For a 10mg vial targeting 0.5mg doses at 0.2mL injection volume, required concentration is still 2.5mg/mL
Este es uno de esos casos, donde la sntesis de una molcula, no solo provee una solucin a un tema de salud tan importante como la diabetes, sino que, adems genera una solucin no planificada
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
"Vitamin B12 deficiency among adult diabetic patients in Uganda: relation to glycaemic control and haemoglobin concentration"
The addition of zinc, selenium, vitamin C, niacinamide (vitamin B3) and vitamin B2 optimises its action for a radiant complexion